IOVA
IOVANCE BIOTHERAPEUTICS, INC.
Key Financials
Operating Income
$-403356000
↓ 2.0%
Net Income
$-390978000
↓ 5.1%
Total Liabilities
$214.6M
↑ 7.3%
Total Assets
$913.2M
↑ 0.3%
Revenue
$263.5M
↑ 60.6%
EPS (Diluted)
$-1.09
↑ 14.8%
Shareholders' Equity
$698.6M
↓ 1.7%
Cash & Equivalents
$163.1M
↑ 41.0%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 4 | 5/13/2026 | View on SEC |
| SCHEDULE 13G | 5/12/2026 | View on SEC |
| 8-K | 5/7/2026 | View on SEC |
| 10-Q | 5/7/2026 | View on SEC |
| ARS | 5/1/2026 | View on SEC |
| DEFA14A | 4/28/2026 | View on SEC |
| DEF 14A | 4/28/2026 | View on SEC |
| PRE 14A | 4/17/2026 | View on SEC |
| SCHEDULE 13G/A | 3/27/2026 | View on SEC |
| 8-K | 3/20/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | IOVA |
| Company Name | IOVANCE BIOTHERAPEUTICS, INC. |
| CIK | 1425205 |
| Sector | Biological Products, (No Diagnostic Substances) |
| Industry | Accelerated filer |
| Exchange | Nasdaq |
| SIC Code | 2836 |
| SIC Description | Biological Products, (No Diagnostic Substances) |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 6502607120 |